Advances in the treatment of multiple myeloma: the role of thalidomide

Página do item simplificado
dc.contributor.authorRibas, Christian [UNIFESP]
dc.contributor.authorColleoni, Gisele Wally Braga [UNIFESP]
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.date.accessioned2016-01-24T12:33:40Z
dc.date.available2016-01-24T12:33:40Z
dc.date.issued2003-01-01
dc.description.abstractMultiple myeloma (MM) accounts for 1% of all malignancies and 10% of malignant hematological neoplasms. in spite of high-dose therapy with stem cell rescue, relapse and disease resistance are common events in the course of the disease. Thalidomide (Thal) has been successfully used in such situations and it's use has also been expanded to the up-front therapy and as adjuvant to stem cell transplantation. Here, we review the underlying concepts and current clinical data regarding Thal in the treatment of MM.en
dc.description.affiliationUniversidade Federal de São Paulo, EPM, Dept Med, Discipline Hematol & Hemotherapy, São Paulo, Brazil
dc.description.affiliationUnifespUniversidade Federal de São Paulo, EPM, Dept Med, Discipline Hematol & Hemotherapy, São Paulo, Brazil
dc.description.sourceWeb of Science
dc.format.extent291-298
dc.identifierhttp://dx.doi.org/10.1080/1042819021000035671
dc.identifier.citationLeukemia & Lymphoma. Abingdon: Taylor & Francis Ltd, v. 44, n. 2, p. 291-298, 2003.
dc.identifier.doi10.1080/1042819021000035671
dc.identifier.issn1042-8194
dc.identifier.urihttp://repositorio.unifesp.br/handle/11600/27102
dc.identifier.wosWOS:000179633700012
dc.language.isoeng
dc.publisherTaylor & Francis Ltd
dc.relation.ispartofLeukemia & Lymphoma
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.rights.licensehttp://journalauthors.tandf.co.uk/permissions/reusingOwnWork.asp
dc.subjectmultiple myelomaen
dc.subjectthalidomideen
dc.subjecttreatmenten
dc.subjectreviewen
dc.titleAdvances in the treatment of multiple myeloma: the role of thalidomideen
dc.typeinfo:eu-repo/semantics/article
Arquivos
Coleções
Em verificação - Geral